Wendy K Nevala

This inventor holds 57 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Treatment (CPC class A61K). Top assignees: Mayo Foundation for Medical Education and Research, Vavotar Life Sciences LLC. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy K Nevala. Retrieved from https://idiyas.com/inventor/wendy-k-nevala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 (Patent Applications = 17)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 7 (Patent Applications = 21)

Average Co-Inventor Count = 2.1

ph-index = 27

Forward Citations = 1,048(Granted Patents)

Forward Citations (Not Self Cited) = 66(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rohester, MN (US) (2019)
Rochester, MN (US) (2016 - 2024)

Company Filing History:

57 out of 1,808

Mayo Foundation for Medical Education and Research

patents

1 out of 1

Vavotar Life Sciences LLC

patent

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

Nanoparticle Complexes

Cancer Treatment

Antibody Compositions

Paclitaxel

Albumin

VEGF

Triple-Negative Breast Cancer

Hematologic Cancers

Carrier Proteins

Polypeptide-Antibody Complexes

Therapeutic Index

Chemotherapeutic Drugs

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403119 - Treating lymphomas (2025-09-02),

2. 12364754 - Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab (2025-07-22),

3. 12161718 - Unit dose of a composition for treating cancer (2024-12-10),

4. 11971412 - Polypeptide-antibody complexes and uses thereof (2024-04-30),

5. 11878061 - Methods for improving the therapeutic index for a chemotherapeutic drug (2024-01-23),

6. 11872205 - Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins (2024-01-16),

7. 11660339 - Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment (2023-05-30),

8. 11655301 - Carrier-binding agent compositions and methods of making and using the same (2023-05-23),

9. 11648311 - Cancer treatments (2023-05-16),

10. 11590098 - Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins (2023-02-28),

11. 11548946 - Carrier-PD-L1 binding agent compositions for treating cancers (2023-01-10),

12. 11531030 - Polypeptide-antibody complexes and uses thereof (2022-12-20),

13. 11433023 - Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same (2022-09-06),

14. 11427637 - Methods of treating PD-L1 expressing cancer (2022-08-30),

15. 11351254 - Hematologic cancer treatments (2022-06-07),

Title: Trailblazing Healthcare Innovator: The Inspiring Journey of Wendy K Nevala

Introduction: Wendy K Nevala, a dedicated inventor based in Rochester, MN, has earned a stellar reputation in the field of healthcare technology through her unwavering commitment to innovation and excellence. With 54 patents to her name, Wendy's pioneering work continues to motivate aspiring inventors to innovate and push boundaries in the healthcare industry.

Latest Patents: Among Wendy's latest patents is the groundbreaking "Polypeptide-antibody complexes and uses thereof," which describes complexes containing a labeled polypeptide and an antibody. These complexes serve as valuable tools in research, diagnostics, and clinical applications. Additionally, Wendy has developed methods for enhancing the therapeutic index of chemotherapeutic drugs, particularly in cancer treatment, by reducing chemotherapy-related toxicity such as liver toxicity.

Career Highlights: Wendy Nevala has made significant contributions to healthcare technology through her roles at esteemed institutions such as the Mayo Foundation for Medical Education and Research, where she has been instrumental in developing innovative solutions to address critical healthcare challenges. Her relentless pursuit of excellence has led to the issuance of multiple patents that have improved patient outcomes and advanced the field of healthcare technology.

Collaborations: Throughout her career, Wendy has collaborated with esteemed colleagues such as Svetomir N Markovic and Gerald F Swiss. These collaborations have been instrumental in driving forward cutting-edge research and development initiatives, resulting in the successful commercialization of novel technologies in the healthcare sector.

Conclusion: Wendy K Nevala's remarkable journey as a trailblazing healthcare innovator serves as a testament to her passion for innovation and her dedication to improving healthcare technologies. Her pioneering work has not only advanced the field but also inspired future generations of inventors to continue striving for excellence in healthcare innovation.

Profile summary based on public USPTO records.